Effects of Losartan or Atenolol in Hypertensive Patients without Clinically Evident Vascular Disease: A Substudy of the LIFE Randomized Trial Academic Article uri icon

Overview

MeSH Major

  • Antihypertensive Agents
  • Atenolol
  • Cardiovascular Diseases
  • Hypertension
  • Hypertrophy, Left Ventricular
  • Losartan

abstract

  • In hypertensive patients without clinically evident vascular disease, losartan was more effective than atenolol in preventing cardiovascular morbidity and death, predominantly stroke, independent of blood pressure reduction.

publication date

  • August 5, 2003

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 12899584

Additional Document Info

start page

  • 169

end page

  • 77

volume

  • 139

number

  • 3